Neurology: Disease Deep Dive

Podcast details

Technical and general information from the podcast's RSS feed.

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

Publication history

Monthly episode publishing history over the past years.

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Advances in the Evaluation of TBI

Tuesday, June 4, 2024 • Duration 20:44

Welcome to Neurology: Disease Deep Dive. In this episode, Dr. Beth McQuiston, MD, RD, Medical Director at Abbott Laboratories, and Dr. David Okonkwo, MD, PhD, Professor of Neurological Surgery, Clinical Director of the Brain Trauma Research Center, and Director of the Neurotrauma Program at University of Pittsburgh Medical Center discuss evaluation and advances in evaluation of traumatic brain injury. Dr. McQuiston is talking with us today on behalf of Abbott, which is sponsoring this podcast. Dr. Okonkwo is a physician scientist whose research on blood biomarkers was instrumental for advancing traumatic brain injury biomarker diagnostics. Resources from this episode: More information on concussions Information on i-STAT TBI test cartridge with the i-STAT Alinity instrument Information on Alinity i TBI test

Read moreCollapse

NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

Thursday, February 29, 2024 • Duration 20:14

In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents an overview of NMOSD treatment, including goals, triggers, and considerations for switching therapies. DA-UNBR-US-02296-2 05/2024 Sponsored by Horizon Therapeutics

Read moreCollapse

NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity

Thursday, February 15, 2024 • Duration 22:53

In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents the importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity. DA-UNBR-US-02295-2 05/2024 Sponsored by Horizon Therapeutics

Read moreCollapse

NMOSD Part 1 - Overview and important considerations for diagnosis

Thursday, February 1, 2024 • Duration 31:51

In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podcast. In this episode, Dr. Robertson presents an overview of NMOSD, and important considerations for diagnosis. DA-UNBR-US-02294-2 05/2024 Sponsored by Horizon Therapeutics

Read moreCollapse

Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders

Tuesday, December 5, 2023 • Duration 27:38

In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.

Read moreCollapse

The Evolving Therapeutic Landscape for Parkinson Disease

Friday, June 6, 2025 • Duration 20:39

Mark Stacy, MD, William E. Murray Professor of Neurology, Medical University of South Carolina, Charleston, SC, discusses the evolving therapeutic landscape for Parkinson disease, highlighting promising advances in neuroprotective therapies, biomarkers, personalized medicine, and innovative clinical trial designs that aim to improve both treatment outcomes and accessibility.

Read moreCollapse

Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations

Wednesday, October 22, 2025 • Duration 19:03

Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist clinicians with early detection and differentiation of these conditions.

Read moreCollapse

Advances in ALS: New Targets, Trials, and Care Strategies

Monday, October 27, 2025 • Duration 14:57

Merit Cudkowicz, MD, Julieanne Professor of Neurology, Harvard Medical School, Boston, MA, discusses the evolving landscape of treatment for ALS, including FDA-approved disease-modifying therapies, the importance of genetic testing, the emergence of gene therapies, and the promising clinical trial pipeline targeting genetic and sporadic forms of ALS.

Read moreCollapse

Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies

Wednesday, December 3, 2025 • Duration 13:47

Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses current standards of care for low- and high-grade gliomas, including the importance of comprehensive molecular testing, the World Health Organization classification of tumors of the central nervous system, and newly available therapies.

Read moreCollapse

Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice

Tuesday, December 2, 2025 • Duration 23:51

Hope O’Brien, MD, MBA, FAHS, FAAN, Founder and CEO of the Headache Center of Hope, Cincinnati, OH, discusses challenges and considerations for adult headache neurologists who are onboarding adolescent patients as they transition from pediatric practice. Dr. O’Brien highlights a framework with strategies for a seamless transition, while noting best practices for promoting patient autonomy and mental wellbeing.

Read moreCollapse

Neurology: Disease Deep Dive – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Neurology: Disease Deep Dive – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify